Indies Pharma Jamaica Limited (JMSE:INDIES)

Jamaica flag Jamaica · Delayed Price · Currency is JMD
3.370
-0.180 (-5.07%)
At close: Mar 12, 2025
24.81%
Market Cap4.49B
Revenue (ttm)1.18B
Net Income (ttm)256.04M
Shares Out1.33B
EPS (ttm)0.19
PE Ratio17.63
Forward PEn/a
Dividend0.11 (3.26%)
Ex-Dividend DateMar 31, 2025
Volume3,263
Average Volume129,212
Open3.235
Previous Close3.550
Day's Range3.370 - 3.380
52-Week Range2.250 - 4.180
Beta0.18
RSI47.42
Earnings DateSep 10, 2025

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2003
Employees 65
Stock Exchange Jamaica Stock Exchange
Ticker Symbol INDIES
Full Company Profile

Financial Performance

In 2024, Indies Pharma Jamaica's revenue was 1.16 billion, an increase of 9.81% compared to the previous year's 1.06 billion. Earnings were 251.77 million, an increase of 15.69%.

Financial Statements

News

There is no news available yet.